Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00783029 · ClinicalTrials.gov registry record
Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)
A clinical trial, sponsored by Penn State University.
- Completed
- Registry status
- 87
- Enrollment target
NCT00783029: Completed study, sponsored by Penn State University.
NCT00783029 is a clinical trial that has completed, run by Penn State University. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00783029 has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
The purpose of this research study is examine the response of the blood vessels in the eye to a light flicker stimulus using the Dynamic Vessel Analyzer (DVA) on two separate days in healthy individuals. The DVA uses an instrument which is used during routine eye examinations. The hypothesis of the study is that the changes in eye's blood vessel will be similar between the two visits; thus establishing reproducibility of the measurements for future comparisons to individuals with stroke or heart disease. In addition, this study will compare the eye's blood vessel responses to responses of the blood vessels in the arm using Doppler ultrasound.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-12 |
What the finished NCT00783029 record still lists
NCT00783029 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00783029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00783029 about?
NCT00783029 is a clinical study titled "Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)". The purpose of this research study is examine the response of the blood vessels in the eye to a light flicker stimulus using the Dynamic Vessel Analyzer (DVA) on two separate days in healthy individuals. The DVA uses an instrument which is used during routine eye examinations. The hypothesis of the ...
What is the current status of trial NCT00783029?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2008-10. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT00783029?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia